• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Truffle Capital

edit

Truffle Capital is a leading independent European private equity firm originally set up for investing in technology spin-offs.

Truffle Capital invests exclusively in Energy, Information Technologies, and Life Sciences companies throughout Europe. The firm is led by a team of four General Partners with decades of successful investment and entrepreneurial experience in Europe and Silicon Valley. They are business-builders who bring a hands-on approach to turning portfolio companies into technology and market leaders.

Recent Milestones

edit

• 
  Truffle Capital invested in SP3H. (5/22/12)
  Posted 5/22/12 at 1:48am via finsmes.com
• 
  Truffle Capital invested in Pharnext. (2/9/12)
  Posted 2/9/12 at 4:23am via finsmes.com
• 
  Truffle Capital invested in Pharnext. (9/8/11)
  Posted 9/8/11 at 7:37pm via pharnext.com
• 
  Truffle Capital invested in MyoPowers Medical Technologies. (7/5/11)
  Posted 7/5/11 at 6:58pm via finsmes.com
• 
  Truffle Capital invested in Utel. (6/30/11)
  Posted 6/30/11 at 1:09am via finsmes.com
• 
  Truffle Capital invested in Pharnext. (6/14/10)
  Posted 6/15/10 at 5:30pm via onbiovc.com
• 
  Truffle Capital invested in Immune Targeting Systems. (3/17/10)
  Posted 3/18/10 at 3:32am via onbiovc.com
• 
  Truffle Capital invested in PeopleCube. (9/20/07)
  Posted 2/17/10 at 1:16pm via peoplecube.com
• 
  Truffle Capital invested in Neovacs. (7/17/07)
  Posted 3/12/10 at 8:31pm via neovacs.fr
• 
  Truffle Capital invested in Cytomics Pharmaceuticals. (2/28/06)
  Posted 4/23/10 at 3:36am via rubicon-net.org
• 
  Truffle Capital invested in RF-iT Solutions. (1/26/06)
  Posted 4/20/10 at 10:28pm

Investments

Videos

Sources

1. SP3H Raises €2.2M in Funding (finsmes.com) [edit]
2. Pharnext Raises €8M in Funding (finsmes.com) [edit]
3. PHARNEXT announces a €2.5 million round of financing (pharnext.com) [edit]
4. MyoPowers Medical Technologies Closes CHF16M Series B Financing Round (finsmes.com) [edit]
5. Utel Raises €2.8M in Funding (finsmes.com) [edit]
6. Pharnext, SAS: Series A $5.8M (onbiovc.com) [edit]
7. Immune Targeting Systems, Ltd.: Series A $13.2 (onbiovc.com) [edit]
8. PeopleCube Secures $17M in Funding From Truffle Capital and Big Bang Ventures (peoplecube.com) [edit]
9. Neovacs, a leading biotech company in the field of therapeutic vaccines in oncology and inflammatory diseases, raises 13 million Euros from a international group of specialist investors, including the Novartis Venture Fund and Truffle Capital (neovacs.fr) [edit]
10. CYTOMICS SYSTEMS COMPLETES A € 10 MILLION ROUND OF FINANCING (rubicon-net.org) [edit]
11. EDGAR [edit]